Therefore, we hypothesized that application of α-gal nanoparticles to wounds, or injection of these nanoparticles into myocardium injured by ischemia, results in binding of anti-Gal to α-gal epitopes on the nanoparticles (Step 1 in Figure 1B). The gene discussed is GAL; the disease is ischemia.